In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...